Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9178386 | Nutrition, Metabolism and Cardiovascular Diseases | 2005 | 8 Pages |
Abstract
Available information collectively suggests that although HHcy can be regarded as a minor risk factor for coronary heart disease, it interacts with other risk factors in triggering new events in patients with known CAD. Thus, the treatment of mild HHcy with folate supplementation is appropriate in particular in high risk patients or patients with established CAD who do not present with the “traditional” risk factors.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Maurizio Cesari, Gian Paolo Rossi, Daniele Sticchi, Achille C. Pessina,